Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #338368 on Amarin Corp Plc (AMRN)
sts66
05/04/21 6:35 PM
#338515 RE: louieblouie #338368
even accepting Amarin’s allegations as true, coverage for the Hikma generic is only approximately one-fourth of the total volume of Amarin’s brand product.
Amarin alleges Health Net induces infringement by listing Amarin’s brand drug product on a lower tier and offering more favorable payment terms for the generic product despite knowing others purportedly use the generic product to infringe.
Any evidence purportedly showing a pharmacist is induced by the pharmacy plan would contradict evidence other sources (e.g, the prescription, Hikma’s label, or Hikma’s press releases) encouraged the pharmacist’s infringement.